Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine
Go back to Novavax NanoFlu™ Vaccine Demonstrates Improved Immune Responses Compared to Egg-Based, High-Dose Flu Vaccine| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.99 -1.02 (9.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.01 | 52 Week High | $9.23 | |||
| Open | $10.79 | 52 Week Low | $1.16 | |||
| Day High | $10.87 | P/E | N/A | |||
| Day Low | $9.56 | EPS | $-0.30 | |||
| Volume | 12,196,986 | |||||
| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 9.99 -1.02 (9.26%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.01 | 52 Week High | $9.23 | |||
| Open | $10.79 | 52 Week Low | $1.16 | |||
| Day High | $10.87 | P/E | N/A | |||
| Day Low | $9.56 | EPS | $-0.30 | |||
| Volume | 12,196,986 | |||||



